UK Edition. Click here for US version.
IMIPRAMINE 25MG TABLETS
Active substance(s): IMIPRAMINE HYDROCHLORIDE / IMIPRAMINE HYDROCHLORIDE / IMIPRAMINE HYDROCHLORIDE
210 X 297MM
Patient information leaflet
IMIPRAMINE 25 MG TABLETS BP
Read all of this leaflet carefully before you start taking this
medicine. It contains important information.
• Keep this leaflet. You may want to read it again.
• If you have any other questions, or if there is something you do not
understand, please ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Never give it to
someone else. It may not be the right medicine for them even if their
signs of illness are the same as yours.
If you get any side effects talk to your doctor or pharmacist. This
includes any possible side effects not listed in this leaflet. See section 4.
What is in this leaflet:
1 What Imipramine is and what it is used for
2. What you need to know before you take Imipramine Tablets
3. How to take Imipramine Tablets
4. Possible side effects
5. How to store Imipramine Tablets
6. Contents of the pack and other information
1. What Imipramine is and what it is used for
Imipramine belongs to a class of antidepressant drugs known as the
tricyclic antidepressant drugs. These medicines alter the levels of
chemicals in the brain to relieve the symptoms of depression.
Imipramine is used to treat depression. It can also be used to treat bedwetting in children.
2. What you need to know before you take Imipramine
Do not take this medicine if you:
• have previously suffered an allergic reaction while taking this
medicine or any other tricyclics antidepressants
• are allergic to any of the other ingredients in this medicine (see
section 6 - further information)
• suffer from glaucoma (increased eye pressure)
• have heart disease such as irregular heartbeats, heart block or
recently had a heart attack
• suffer from severe liver disease
• suffer from periods of increased and exaggerated behaviour (mania)
• suffer with porphyria (a genetic disorder of the red blood cells
haemoglobin causing skin blisters, abdominal pain and brain/nervous
• have difficulty passing water
• are taking monoamine oxidase inhibitors (MAOIs), such as
moclobemide, or you have taken MAOIs within the previous 14
days for depression
This medicine should not be given to children under 6 years of age.
Thoughts of suicide and worsening of your depression or anxiety
If you are depressed and/or have anxiety disorders you can sometimes
have thoughts of harming or killing yourself. These may be increased
when first starting antidepressants, since these medicines all take time to
work, usually about two weeks but sometimes longer.
You may be more likely to think like this:
• if you have previously had thoughts about killing or harming
• if you are a young adult. Information from clinical trials has shown
an increased risk of suicidal behaviour in young adults (less than 25
years old) with psychiatric conditions who were treated with an
If you have thoughts of harming or killing yourself at any time,
contact your doctor or go to a hospital straight away.
You may find it helpful to tell a relative or close friend that you are
depressed or have an anxiety disorder, and ask them to read this leaflet.
You might ask them to tell you if they think your depression or anxiety
is getting worse, or if they are worried about changes in your behaviour.
Warnings and precautions
Talk to your doctor or pharmacist before taking Imipramine tablets if
you or your child (if the child is the patient):
• suffer from any mental illness (psychiatric disorder) other than
depression (e.g. schizophrenia or manic depression)
• are withdrawing from alcohol or medicines used to treat fits
• have ever had glaucoma
• have an enlarged prostate gland
• have an overactive thyroid gland and are taking medicines to treat a
suffer from epilepsy (fits) or brain damage
suffer from constipation
have low blood pressure or problems with your circulation
have a tumour of the adrenal gland (e.g. phaeochromocytoma or
suffering from severe kidney disease
suffer from panic attacks
wear contact lenses as the use of Imipramine may lead to eye
are being given electroconvulsive therapy (ECT)
are due to have any surgery, including dentistry that involves an
Having operations and tests
If you are to undergo surgery or medical tests tell your doctor or dentist
that you are taking Imipramine.
Taking other medicines
Tell your doctor or pharmacist if you are taking, have recently taken or
might take any other medicines including medicine obtained without a
• medicines for epilepsy, e.g. phenytoin, barbiturates, and
• medicines such as sleeping tablets or tranquillisers including
diazepam, nitrazepam, oxazepam and alprazolam
• medicines to treat depression, such as selective serotonin reuptake
inhibitors (SSRIs) such as fluxetine, fluvoxamine
• disulfiram, a drug used in the treatment of alcohol abuse
• nicotine replacement therapy
• methylphenidate, a drug used in the treatment of childhood
• medicines used to thin the blood (anticoagulants, e.g. warfarin)
• medicines (antihistamines) used for colds, sinuses, hay fever or
• altretamine (to treat some types of cancer)
• alpraclonidine and brimonidine (to treat glaucoma)
• baclofen (a muscle relaxant)
• painkillers such a nefopam, tramadol, codeine, dihydrocodeine
• medicines used for heart disease, such as diltiazem, verapamil,
labetalol, propranolol and quinidine
• medicines to treat angina that you spray or dissolve under your
tongue (e.g. glyceryl trinitrate “GTN”, isosorbide dinitrate)
• medicines used for high blood pressure such as guanethidine,
debrisoquine, bethanidine, methyldopa, reserpine, clonidine or
diuretics (water tablets)
• medicines to treat some mental illnesses such as phenothiazines (e.g.
chlorpromazine, thioridazine) and atropine
• cimetidine, a drug used in the treatment of ulcers
• drugs used to treat Parkinson’s disease (e.g. entacapone, selegiline,
orphenadrine, procyclidine and biperiden)
• oral contraceptives (“the pill”) or oestrogens (e.g. used for hormone
• appetite suppressants
• sympathomimetic medicines such as adrenaline (epinephrine),
ephedrine, isoprenaline, noradrenaline (nor epinephrine),
phenylephrine, phenylpropanolamine (these may be present in many
cough and cold remedies or local anaesthetics)
• ritonavir (to treat HIV)
• bronchodilators, which are used to help your breathing
Pregnancy and breast-feeding
Imipramine tablets should not be taken during pregnancy or if breastfeeding. If Imipramine tablets are taken in the last 3 months, the baby
may be born with breathing difficulties, lethargy, colic, irritability,
changes in blood pressure, tremors, spasm. Imipramine tablets should be
withdrawn at least 7 weeks before the expected delivery date.
Driving and using machines
Imipramine may impair your alertness or cause drowsiness or blurred
vision; alcohol can make these symptoms worse. Make sure you are not
affected before you drive or operate machines.
IMIPRAMINE PIL :00430515/02
210 X 297MM
During your treatment with Imipramine tablets, your doctor may wish to
carry out a number of tests on your heart, blood and liver. This is quite
usual and nothing to be concerned about.
Dental check ups
You should have regular dental check-ups whilst taking Imipramine.
Imipramine can cause dryness of the mouth, which may increase the risk
of tooth decay.
If you have been told you have an intolerance to some sugar, contact
your doctor before taking this medicine, as it contains a type of sugar
called lactose or sucrose.
3. How to take Imipramine
Always take this medicine exactly as your doctor has told you. The
pharmacist’s label should tell you how much to take and how often. If it
does not or you are not sure ask your doctor or pharmacist.
• The tablet should be swallowed with a glass of water.
• You are advised not to drink alcohol with this medicine.
• Keep taking your medicine until your doctor tells you to stop.
• Do not stop because you do not feel any better.
• This medicine may take up to four weeks to work.
• Adults: Initially 25mg (one tablet) one to three times daily.
If necessary, your doctor may increase this dose gradually up to 150200mg per day. In severe cases (treated in hospital) the dose may be
increased up to a maximum of 100mg three times a day. The usual
maintenance dose is between 50mg and 100mg a day in divided
• Elderly: Lower doses may be used. Initially 10mg at night
increasing gradually up to 30 - 50 mg daily in divided doses.
For Bed wetting: Children only (To be taken at bedtime and for no
longer than 3 months):
Under 6 years – not recommended
6-7 years (body weight 20-25kg or 44-55lbs): 25mg a day.
8-11 years (body weight 25-35kg or 55-77lbs): 25-50mg a day.
Over 11 years (body weight 35-54kg or 77-119lbs): 50-75mg a day.
If you take more medicine than you should
If you or anyone else has swallowed a lot of the tablets all together,
contact your nearest hospital casualty department or doctor immediately.
Symptoms of an overdose include fast or irregular heartbeat, low blood
pressure, drowsiness, fits, coma, agitation, muscle rigidity, being sick or
If you forget to take a dose
If you forget to take a tablet, do not take the missed dose until the next
dose is due. Do not take two doses together. If you see another doctor or
go into hospital, let the doctor or the hospital staff know what medicines
you are taking.
If you stop taking the medicine
If you need to stop taking your medicine, your doctor will advise you
about reducing the dose gradually to avoid unwanted effects.
You may experience withdrawal symptoms if you stop the treatment too
quickly. These may include sleeping problems, irritability and sweating.
If you have any further questions on the use of this product, ask your
doctor or pharmacist.
4. Possible side effects
Like all the medicine, Imipramine tablets can cause side effects in some
people, particularly the elderly, although not everybody gets them
STOP TAKING the tablets and contact a doctor at once if you have
the following allergic reaction; pneumonitis (fever, chills, cough,
difficulty breathing, unusual weight loss, and feeling sick), skin rash or
itching, sore throat, shortness of breath, shock and collapse, increased
sensitivity to sunlight, swollen face, or tongue.
Tell your doctor if you notice any of the following side effects or
notice any other effects not listed
• Blood: reduction in some blood cells (you may experience a sore
throat, mouth ulcers and recurring infections, bleeding or bruising
• Endocrine system and metabolism: disturbances in sexual function
or sex drive, breast swelling in men and women, production or overproduction of breast milk, changes in blood sugar levels, trembling
and weight gain or loss, SIADH (syndrome of inappropriate
antidiuretic hormone secretion)
• Brain and central nervous system: disorientation, light-headedness
(especially when standing up), dizziness, tiredness or sleepiness,
weakness, headache, muscle spasm difficulty concentrating,
agitation, mood changes, delirium (confusion), tremor,
aggressiveness, difficulty in sleeping, delusions, hallucinations
(seeing things that are not there), restlessness, pins and needles, or
lack of muscle control, difficulty in speaking, fits. Anticholinergic
effects (dry mouth, constipation, blurred or double vision, sweating,
hot flushes, difficulty passing water (urine), dilation of the pupil of
the eye, glaucoma and intestinal obstruction)
• Heart: feeling faint when getting up (postural hypotension), high or
severely low blood pressure, fast/racing heart, palpitations, irregular
heart-beats, changes in ECG readings
• Stomach and intestines: feeling or being sick, anorexia (loss of
appetite), inflammation of the mucous membranes in the mouth,
• Liver: impaired liver function, hepatitis, including changes in liver
function (as seen in blood tests), jaundice (yellowing of the skin
and/or whites of the eyes)
• Other: drowsiness; eye pain; loss of balance; muscle weakness or
stiffness; brownish spots on skin; hair loss, ringing in the ears, small
purple red spots. An increased risk of bone fractures has been
observed in patients taking this type of medicine.
• Withdrawal symptoms: nausea (vomiting); feeling or being sick,
stomach pain, diarrhoea, nervousness, anxiety, irritability
• Children: changes in behaviour.
• Imipramine may also increase your feelings of anxiety at the start of
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This
includes any possible side effects not listed in this leaflet. You can also
report side effects directly via the Yellow Card Scheme at:
www.mhra.gov.uk/yellowcard. By reporting side effects you can help
provide more information on the safety of this medicine.
5. How to store Imipramine
Keep all the medicines out of the sight and reach of children.
• Do not use this medicine after the expiry date which is stated on the
label, carton, and blister after ‘EXP’. The expiry date refers to the
last date of that month.
• Imipramine Tablets should be stored at room temperature below
25ºC, in a dry place and protected from light.
• Keep the container tightly closed.
• Store in the original container.
Do not throw away any medicines via wastewater or household waste.
Ask your pharmacist how to throw away medicines you no longer use.
These measures will help to protect the environment.
6. Contents of the pack and other information
What Imipramine tablets contain:
• The active substance is 25mg of Imipramine Hydrochloride.
• The other ingredients are lactose monohydrate, maize starch,
povidone, magnesium stearate, stearic acid, polyvinyl acetate
phthalate, ethyl acetate, talc, calcium carbonate, acacia, sucrose,
shellac, yellow carnauba wax and white beeswax. The tablets contain
the colours titanium dioxide (E171), tartrazine aluminium lake
(E102), amaranth aluminium lake (E123), erythrosine aluminium lake
(E127) and indigo carmine aluminium lake (E132) and the
preservative sodium benzoate (E211)
What Imipramine tablets look like and contents of the pack:
• Imipramine tablets 25mg are red-brown, circular, sugar coated tablets.
• Pack sizes of Imipramine 25mg tablets are 7, 14, 28, 56, 84, 100, 500
and 1000 tablets in containers.
Marketing Authorization holder and Manufacturer:
Pharmvit Ltd, 177 Bilton Road, Perivale,
Greenford, Middlesex UB6 7HQ.
Telephone: 0208 997 5444
0208 997 5433
To request a copy of this leaflet in large print or audio format, please
contact the licence holder at the address (or telephone, fax) above.
PL 04556 / 0043
This leaflet was last revised on May 2015
Source: Medicines and Healthcare Products Regulatory Agency
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.